The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015-2020.
Liang X, Yang Q, Wu P, He C, Yin L, Xu F, Yin Z, Yue G, Zou Y, Li L, Song X, Lv C, Zhang W, Jing B.
Liang X, et al. Among authors: xu f.
Bioorg Chem. 2021 Aug;113:105011. doi: 10.1016/j.bioorg.2021.105011. Epub 2021 May 24.
Bioorg Chem. 2021.
PMID: 34091289
Review.